Skip to main content
Announcements and latest updates
- Oral steroids should be avoided in patients with bronchiectasis, unless there is a clear indication for an alternative comorbidity, such as asthma.
- Although there is evidence for benefit of inhaled corticosteroids (ICS) for patients with COPD and elevated eosinophil counts, studies in bronchiectasis with eosinophilia are yet to report.
- Patients with concomitant COPD and bronchiectasis should receive ICS in line with current COPD guidance.
- Patients with isolated bronchiectasis and an eosinophilia may benefit from a trial of ICS. Advice from a bronchiectasis expert is strongly recommended.
Quality prescribing strategy for respiratory: a guide for improvement
